Format

Send to

Choose Destination
See comment in PubMed Commons below
Am J Clin Nutr. 1997 May;65(5 Suppl):1578S-1580S.

Some Food and Drug Administration perspectives of fat and fatty acids.

Author information

1
Center for Food Safety and Applied Nutrition, US Food and Drug Administration, Washington, DC 20204, USA. fes@cfsan.fda.gov

Abstract

Because of public health concerns about the amount of fat in the American diet, the Food and Drug Administration and the US Department of Agriculture have emphasized use of the recently reformed food label to inform consumers about the fat and fatty acid contents of foods. The health effects of specific fatty acids continue to be the subject of much research, discussion, and debate. Issues that must be addressed to further improve the communication effectiveness of the food label include health effects of n-3 and n-6 fatty acids; appropriate labeling of trans fatty acids, stearic acid, and other non-cholesterol-raising fatty acids; partially absorbed fats; and label claims, especially health claims, for specific fatty acids and fatty acids of biotechnologically altered foods.

PMID:
9129497
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for HighWire
    Loading ...
    Support Center